For research use only. We do not sell to patients.
BMS-962212
CAS No. : 1430114-34-3
Biological Activity：BMS-962212 is a direct, reversible, selective factor XIa (FXIa) inhibitor . BMS-962212 is well tolerated, with fast onset of pharmacodynamic (PD) responses and rapid elimination. BMS-962212 increases exposure dependently in activated partial thromboplastin time, and decreases exposure dependently in FXI clotting activity.
Research Area：Cardiovascular Disease
Targets：Factor Xa
Related Screening Libraries:Clinical Compound Library Plus;Bioactive Compound Library Plus;
Related Small Molecules:Bismuth subgallate;Suc-Ile-Glu(γ-pip)-Gly-Arg-pNA hydrochloride;Razaxaban hydrochloride;Betrixaban-d6;Boc-Ile-Glu-Gly-Arg-AMC;Gabexate mesylate;RWJ-445167;FXIa-IN-8;BMS-654457;Milvexian;Fitusiran;Darexaban;Delparantag;Betrixaban maleate;FXIa-IN-9;FXa-IN-1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
